Sadegh Davoudi

Sadegh Davoudi

Auto-generated profile, based on publicly available information

Sadegh Davoudi

Inst Biomed Engn, Toronto, ON M5S 3G9, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Biomaterials
Verified
Journal Article
Closed access
SDSadegh Davoudi
Sadegh Davoudi
CCChih-Ying Chin
Chih-Ying Chin
MCMichael J. Cooke
Michael J. Cooke
RTRoger Y. Tam
Roger Y. Tam
MSMolly S. Shoichet
Molly S. Shoichet
PGPenney Gilbert
Penney Gilbert

28 August 2017 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
HSHelia Safaee
Helia Safaee
MBMohsen A. Bakooshli
Mohsen A. Bakooshli
SDSadegh Davoudi
Sadegh Davoudi
RCRichard Y. Cheng
Richard Y. Cheng
AMAditya J. Martowirogo
Aditya J. Martowirogo
PGPenney Gilbert
Penney Gilbert

1 April 2016 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JMJames B. Morrissey
James B. Morrissey
RCRichard Y. Cheng
Richard Y. Cheng
SDSadegh Davoudi
Sadegh Davoudi
PGPenney Gilbert
Penney Gilbert

1 February 2022 in Experimental Cell Research
Verified
Journal Article
Closed access
LMLouise A. Moyle
Louise A. Moyle
SDSadegh Davoudi
Sadegh Davoudi
PGPenney Gilbert
Penney Gilbert

29 January 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ANAllison M. L. Nixon
Allison M. L. Nixon
ADAlejandro Duque
Alejandro Duque
NYNicholas Yelle
Nicholas Yelle
MMMegan McLaughlin
Megan McLaughlin
SDSadegh Davoudi
Sadegh Davoudi
JMJason Moffat
Jason Moffat
Cell surface antigen discovery is of great interest for biomedical research both for isolation of rare cell populations and therapeutic targeting. We developed a rapid, cost-effective, fully in vitro technology which facilities the simultaneous target discovery and human antibody generation on the surface of virtually any cell population of interest. We apply our technique to human colorectal cancer-initiating cells (CICs) and identify hundreds of unique human antibodies. We characterized the top three antibody candidates targeting these CICs and identify their protein targets as integrin α7 (ITGA7), HLA-A1 and integrin β6 (ITGB6). We demonstrate that these antibodies can be used to isolate self-renewing colorectal CICs, and that the integrin α7 antibody can prospectively identify glioblastoma brain tumor initiating cells as well as human muscle stem cells. We also demonstrate that genetic ablation of integrin β6 impedes colorectal CIC function. The methodology can be readily applied to other cell populations including stem cells, cancer, or immune cells to facilitate the rapid identification of novel targets and simultaneous generation of potent and specific antibodies with therapeutic potential.

1 March 2017
Verified
Book Chapter
Open access
PDF file
SDSadegh Davoudi
Sadegh Davoudi
PGPenney Gilbert
Penney Gilbert
Hydrogels, a type of biomaterial, are an invaluable part of biomedical research as they are highly hydrated and properties such as elasticity, porosity, and ligand density can be tuned to desired values. Recently, culture substrate stiffness was found to be an important regulator of muscle stem cell self-renewal. Polyethylene glycol (PEG), a synthetic polymer, can be fabricated into hydrogels that match the softness of skeletal muscle tissue, thereby providing a culture surface that is optimal for maintaining muscle stem cell self-renewal potential ex vivo. In this Chapter, we describe a method to produce flat PEG hydrogels across a range of stiffnesses, including a formulation that matches the bulk stiffness of healthy skeletal muscle (12 kPa), while maintaining a constant ligand density. Since PEG is inert to protein adsorption, the steps required to surface functionalize the hydrogel with an adhesive interface (e.g., laminin) are also described.